This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Company Filing History:
1 out of 834,350 Years Active: 2003
Title: Morris Notelivitz: Innovator in Neurodegeneration Treatment
Introduction
Morris Notelivitz is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of neurodegeneration and cognitive health. His innovative work focuses on developing compositions and methods aimed at treating or preventing cognitive decline associated with Alzheimer's disease and other related disorders.
Latest Patents
Morris Notelivitz holds a patent for a composition titled "COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING NEURODEGENERATION AND COGNITIVE DECLINE AND DYSFUNCTION ASSOCIATED WITH ALZHEIMER'S DISEASE, AGING, OTHER DEMENTIA RELATED DISORDERS AND ESTROGEN DEFICIENCY RELATED CONDITIONS." This composition is designed to improve memory and concentration in mammals suffering from memory impairment disorders. It includes a combination of at least one phytoestrogen and at least one acetylcholinesterase inhibitor, such as Huperzine A, along with the potential addition of mammalian estrogen.
Career Highlights
Throughout his career, Morris Notelivitz has focused on addressing critical health issues related to cognitive decline. His research has led to the development of effective therapeutic methods that could significantly enhance the quality of life for individuals affected by neurodegenerative conditions.
Collaborations
Morris has collaborated with esteemed colleagues, including Thomas B Clarkson and Mary Susan Anthony. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Morris Notelivitz is a pioneering inventor whose work in neurodegeneration treatment holds promise for improving cognitive health. His innovative compositions and methods represent a significant step forward in addressing memory impairment disorders.